Aptamers Market worth $2.1 Billion By 2020

1
MarketsandMarkets Presents
Aptamers Market worth 2.1 Billion By 2020

2

• The "Aptamers Market - Technology Trend Analysis
  By Applications - Therapeutics, Diagnostics,
  Biosensors, Drug Discovery, Biomarker Discovery,
  Research Applications with Market Landscape
  Analysis - Global Forecasts to 2018 " analyzes
  and studies the major market drivers, restraints,
  and opportunities in North America, Europe, Asia,
  and Rest of the World.
• Browse 14 market data tables with 29 figures
  spread through 171 Slides and in-depth TOC of
  "Aptamers Market - Technology Trend Analysis By
  Applications - Therapeutics, Diagnostics,
  Biosensors, Drug Discovery, Biomarker Discovery,
  Research Applications with Market Landscape
  Analysis Global Forecasts to 2020.
• http//www.marketsandmarkets.com/Market-Reports/a
  ptamers-technology-market-1167.html

3

Early buyers will receive 10 customization on
Reports.
4

• This report studies the global aptamers market,
  with forecast to 2020.
• The global healthcare industry is witnessing a
  paradigm shift, skewed towards point-of-care
  diagnostics, cost-effective treatment modalities,
  and personalized medicine, which not only offers
  efficient early diagnosis, but also treats
  serious illnesses in order to reduce the cost and
  disease burden. Aptamers is one such technology
  with the potential to revolutionize medical
  diagnostics and therapeutics in healthcare.
• This market research report evaluates the global
  market of aptamers by geography, applications,
  and aptamer type. Further, the applications
  market is divided into six segments, namely,
  therapeutics, diagnostics, biosensors, drug
  discovery, biomarker discovery, and research
  applications. Of the above mentioned application
  segments, research applications is the largest
  revenue segment however, biomarker discovery and
  diagnostics will be the fastest-growing segment.

5

• The global aptamers market was valued at 200
  million in the year 2015. At the end of 2013, the
  market is expected to be 287 million and is
  poised to reach approximately 2.1 billion by
  2020, growing at a CAGR of 49.24 from 2015 to
  2020.
• The biomarker discovery, drug discovery and
  diagnostics segments offer vast opportunities for
  key players in this market. The launch of the
  first aptamer drug, Macugen, and the first
  diagnostic test for testing mycotoxins in grains
  has acknowledged the potential of aptamers in
  therapeutics and diagnostics. This scenario is
  expected to further revolutionize the industry
  towards massive growth in the next 5 to 10 years.
• The global market for aptamers is expected to
  grow, backed by technological advancements with
  respect to selection processes and synthesis. The
  market will experience continuous improvements in
  aptamer synthesis and its applicability in drug
  discovery and routine research.

6

• The market is witnessing a trend toward
  development of personalized medicine and
  point-of-care diagnostic tests. Additionally, the
  demand for safe and cost-effective drugs for
  treatment of cancer (which can be fulfilled by
  aptamer therapeutics), will remarkably fuel
  market growth. North America is the largest hub
  for aptamers market,accounting for the largest
  share, followed by Europe and Asia. North America
  and Europe are expected to grow at a steady pace.
  However, the Asia-Pacific market, particularly
  India and China, is expected to witness a boost
  in demand and is poised to register maximum
  growth over the next five years, owing to the
  increased purchasing power of patients.
• The key players in the aptamers market are AM
  Biotechnologies, LLC (U.S.), Aptagen, LLC (U.S.),
  Aptamer Sciences Inc. (South Korea), Aptamer
  Solutions Ltd (U.K.), Base Pair Biotechnologies
  (U.S.), Bioapter S.L. (Spain), Integrated
  Biotechnologies, Inc. (U.S.), NOXXON Pharma AG
  (Germany), OTC Biotech (U.S.), Regado
  Biosciences, Inc. (U.S.), Somalogic, Inc. (U.S.),
  and TriLink BioTechnologies, Inc. (U.S.).

7
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
8
Contact Us
Mr. RohanNorth - Dominion Plaza, 17304 Preston
Road, Suite 800, Dallas, TX 75252Tel
1-888-6006-441Email sales_at_marketsandmarkets.com
 MarketsandMarkets Blog http//twitter.com/marke
tsmarkets
http//www.linkedin.com/company/marketsandmarkets